PTPMT1 and neoplasm: Importantly, current data implies that inhibition of PTPMT1 in normal, non-transformed cells does not cause cell death and thus, within a critical therapeutic window, could be a specific treatment for tumor cells while minimizing off-target effects to normal cells.